$ADMA Biologics(ADMA.US)$ NEWS IMPRESSIVE ER ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update ADMA Biologics reported impressive first quarter 2024 financial results, with a total revenue of $81.9 million, a 44% increase year-over-year. The GAAP net income was $17.8 million, a $24.6 million increase year-over-year. Adjusted EBITDA for Q1 2024 was $26.4 million, a 970% increase year-over-year. The company raised its total revenue guidance for FY 2024 to m...
$ADMA Biologics(ADMA.US)$ $Coinbase(COIN.US)$ $盈透证券(IBKR.US)$ $Spotify Technology(SPOT.US)$ so as much as it sucks apparently reason doesn't win, and here we are about to ban tiktok I guess? because something somethings china-boogeyman. It seems really foolish to upset millions of voters. let alone young voters. and besides their incredibly progressive leanings. I can't imagine what might backfire there. That said. Between this and the fake news (like actually misinformation/sens...
5
举报
Jaguar8 :
AGBA is next to Tiktok after its merger with Triller. Triller is next to Tiktok globally. This merger is 4B and will be consummated soon
Tonyco楼主Jaguar8:
I don't know, it reported 550m users, but it had to delete 200 million fake accounts and bots. since the industry's product is users, they have a vested interest in not doing much to stop it. that tells me if they report 200 mill out of 550m it's probably 300m~ or more. since they had to pay celebs to use it, idk. 380m liabilities... somethings not right.
$ADMA Biologics(ADMA.US)$ This one looks great. Solid fundamentals and technicals. VMACD shows golden cross, but reg macd still hasn't quite yet. Maybe a small dip coming but... worth it.
1
3
举报
Jaguar8 :
It is expected to report EPS of 0.05 which translates to 267% increase from previous quarter and est revenue of 76.7M, up 37% from same quarter last year
ADMA's decision to reduce debt with available cash signals their confidence in rapid earnings growth and sustained cash generation. Their new lender, Ares Management, is also optimistic about ADMA's potential growth.
Caution is urged regarding ADMA Biologics, given heavier insider selling. The biologics business is under scrutiny, with two warnings signaled. Insiders' actions, with more sales than purchases, could be a red flag.
$ADMA Biologics(ADMA.US)$Forming small triangle here. Will it be downside breakout or upside breakout and all the way to 2.15? Volume squeezing, awaiting for the volume surge.
ADMA Biologics股票讨论区
NEWS
IMPRESSIVE ER
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics reported impressive first quarter 2024 financial results, with a total revenue of $81.9 million, a 44% increase year-over-year. The GAAP net income was $17.8 million, a $24.6 million increase year-over-year. Adjusted EBITDA for Q1 2024 was $26.4 million, a 970% increase year-over-year. The company raised its total revenue guidance for FY 2024 to m...
$Coinbase(COIN.US)$
$盈透证券(IBKR.US)$
$Spotify Technology(SPOT.US)$
so as much as it sucks apparently reason doesn't win, and here we are about to ban tiktok I guess? because something somethings china-boogeyman. It seems really foolish to upset millions of voters. let alone young voters. and besides their incredibly progressive leanings. I can't imagine what might backfire there.
That said. Between this and the fake news (like actually misinformation/sens...
This one looks great. Solid fundamentals and technicals. VMACD shows golden cross, but reg macd still hasn't quite yet. Maybe a small dip coming but... worth it.
暂无评论